One Year Trial Evaluating Safety of Ozurdex With Eylea

ClinicalTrials.gov ID: NCT03984110

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03984110. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)

Study identification

NCT ID: NCT03984110
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Texas Retina Associates; Other
Enrollment: 50 participants

Conditions and interventions

Conditions

Diabetic Macular Edema

Interventions

Ozurdex Drug
Eylea Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 11, 2019 (Actual)
Primary completion: Oct 27, 2022 (Actual)
Completion: Oct 27, 2022 (Actual)
Last update posted: Apr 10, 2024

2019 – 2022

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Texas Retina Associates	Dallas	Texas	75231	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03984110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 10, 2024 · Synced Nov 14, 2026